COVID-19, Androgen receptor, SARS-CoV-2, IL-6, enzalutamide
Lung-to-brain metastasis, NSCLC brain colonization, ECM-immune crosstalk, transcriptomic trajectory, LUAD molecular subtypes, COL1A1-integrin axis, stage III LUAD prognosis, brain metastasis biomarkers, HOXC10-PD-L2 pathway, immunosuppressive microenvironment, matched tissue
extensive-stage small cell lung cancer, immunotherapy, chemoimmunotherapy, ablative radiation, stereotactic body radiation therapy